Abstract
New therapeutics are urgently needed to combat the immense disease burden of tuberculosis and related mycobacterial diseases worldwide. Natural products continue to provide leads for the development of novel drugs to treat the rapidly growing numbers of patients with multi- and extensively-drug resistant tuberculosis. This review presents natural products and synthesized analogues with anti-mycobacterial activity published between 2006 through 2009. Structure activity relationships, synthetic analogues and newly reported activities of known compounds reported during this period are also included.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 735-765 |
| Number of pages | 31 |
| Journal | Current topics in medicinal chemistry |
| Volume | 12 |
| Issue number | 7 |
| DOIs | |
| State | Published - Apr 1 2012 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Drug development
- Drug resistant tuberculosis
- Mycobacterium tuberculosis
- Natural products
- Structure activity relationship
- Tuberculosis
Fingerprint
Dive into the research topics of 'Natural products as leads for tuberculosis drug development'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS